Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 7, 2014, Pages 516-524

  Ma, Yanyun ^a,b   Wang, Rui ^a,c   Zhang, Jun ^c   Li, Wenshuai ^c   Gao, Chunfang ^d   Liu, Jie ^a,c   Wang, Jiucun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; MICRORNA; MICRORNA 423; MICRORNA 499; UNCLASSIFIED DRUG; MIRN423 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; LARGE SCALE PRODUCTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME; AGED; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84904247867     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0510     Document Type: Article

References (35)

1. Akkiz H, Bayram S, Bekar A, et al. (2011) Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study. Asian Pac J Cancer Prev 12:3107-3112.
2. Alshatwi AA, Shafi G, Hasan TN, et al. (2012) Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 7:e30049.
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
5. Blum HE (2005) Hepatocellular carcinoma:therapy and prevention. orld J Gastroenterol 11:7391-740. (Pubitemid 43126017)
6. Buonocore F, Hill MJ, Campbell CD, et al. (2010) Effects of cis-regulatory variation differ across regions of the adult human brain. Hum Mol Genet 19:4490-4496.
7. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866. (Pubitemid 44629897)
8. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-714.
9. Duan S Mi S, Zhang W, Dolan ME (2009) Comprehensive analysis of the impact of SNPs and CNVs on human micro-RNAs and their regulatory genes. RNA Biol 6:412-425.
10. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576. (Pubitemid 46890874)
11. Fan C, Chen C, Wu D (2013) The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis. Mol Biol Rep 40:3389-3394.
12. Farazi TA, Horlings HM, Ten Hoeve JJ, et al. (2011) Micro-RNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71:4443-4453.
13. Guled M, Lahti L, Lindholm PM, et al. (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-a miRNA microarray analysis. Genes Chromosomes Cancer 48:615-623.
14. Guo J, Jin M, Zhang M, Chen K (2012) A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One 7:e30585.
15. Hu Z, Chen J, Tian T, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118:2600-2608. (Pubitemid 351949787)
16. Hui AB, Lenarduzzi M, Krushel T, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16:1129-1139.
17. Kim YD, Lee JY, Oh KM, et al. (2011) NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in vivo. Nucleic Acids Res 39:4300-4314.
18. Kontorovich T, Levy A, Korostishevsky M, et al. (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 127:589-597.
19. Lafferty-Whyte K, Cairney CJ, Jamieson NB, et al. (2009) Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim Biophys Acta 1792:341-352.
20. Li LM, Hu ZB, Zhou ZX, et al. (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70:9798-9807.
21. Liang L, Wong CM, Ying Q, et al. (2010) MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 52:1731-1740.
22. Lin J, Huang S, Wu S, et al. (2011) MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 32:1641-1647.
23. Liu Z, Li G, Wei S, et al. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116:4753-4760.
24. Lu X, Zhao H, Yang H, et al. (2009) A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol 100:488-493.
25. Pastinen T, Ge B, Hudson TJ (2006) Influence of human genome polymorphism on gene expression. Hum Mol Genet 15 Spec No 1:R9-R16.
26. Saunders MA, Liang H, Li WH (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300-3305. (Pubitemid 46364154)
27. Smith RA, Jedlinski DJ, Gabrovska PN, et al. (2012) A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics 9:115-118.
28. Wang JX, Jiao JQ, Li Q, et al. (2011) miR-499 regulates mi-tochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17:71-78.
29. Wei W, Hu Z, Fu H, et al. (2012) MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Oncol Rep 28:701-706.
30. Wen J, Friedman JR (2012) miR-122 regulates hepatic lipid metabolism and tumor suppression. J Clin Invest 122:2773-2776.
31. Xiang Y, Fan S, Cao J, et al. (2012) Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39:7019-7023.
32. Xing J, Wan S, Zhou F, et al. (2012) Genetic polymorphisms in pre-microRNA genes as prognostic markers of colo-rectal cancer. Cancer Epidemiol Biomarkers Prev 21:217-227.
33. Xu Y, Liu L, Liu J, et al. (2011) A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 128:412-417.
34. Ye Y, Wang KK, Gu J, et al. (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1:460-469.
35. Zhang J, Wang R, Ma YY, et al. (2013) Association between the single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and the susceptibility to hepatocellular carcinoma in Chinese population. Asian Pac J Cancer Prev 14:6427-6431. Municipality Municipality